Sally Del Principe
Corporate Officer/Principal bei Lupton del Principe Associates Ltd.
Aktive Positionen von Sally Del Principe
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| Lupton del Principe Associates Ltd. | Corporate Officer/Principal | 09.04.2010 | - |
Karriereverlauf von Sally Del Principe
Ehemalige bekannte Positionen von Sally Del Principe
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
HIV-VAC, Inc.
 HIV-VAC, Inc. Miscellaneous Commercial ServicesCommercial Services HIV-VAC, Inc. develops and markets proposed vaccine designed to combat HIV/AIDS. This proposed vaccine, which is called NFU.Ac.HIV, was developed by Dr. Gordon Skinner, director of research, through the University of Birmingham, in the U.K. The proposed vaccine was licensed to Intracell Vaccines Limited from the University of Birmingham. The company was founded in 1997 and is headquartered in Ontario, CA. | Finanzdirektor/CFO | 09.04.2010 | 28.10.2010 |
Statistik
International
| Kanada | 2 |
| Vereinigtes Königreich | 2 |
Operativ
| Director of Finance/CFO | 1 |
| Corporate Officer/Principal | 1 |
Sektoral
| Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
HIV-VAC, Inc.
HIV-VAC, Inc. Miscellaneous Commercial ServicesCommercial Services HIV-VAC, Inc. develops and markets proposed vaccine designed to combat HIV/AIDS. This proposed vaccine, which is called NFU.Ac.HIV, was developed by Dr. Gordon Skinner, director of research, through the University of Birmingham, in the U.K. The proposed vaccine was licensed to Intracell Vaccines Limited from the University of Birmingham. The company was founded in 1997 and is headquartered in Ontario, CA. | Commercial Services |
| Lupton del Principe Associates Ltd. |
- Börse
- Insiders
- Sally Del Principe
- Erfahrung
